Cargando…
High Risk of Hepatocellular Carcinoma Development in Fibrotic Liver: Role of the Hippo-YAP/TAZ Signaling Pathway
Liver cancer is the fourth leading cause of cancer-related death globally, accounting for approximately 800,000 deaths annually. Hepatocellular carcinoma (HCC) is the most common type of liver cancer, making up about 80% of cases. Liver fibrosis and its end-stage disease, cirrhosis, are major risk f...
Autores principales: | Moon, Hyuk, Cho, Kyungjoo, Shin, Sunyeong, Kim, Do Young, Han, Kwang-Hyub, Ro, Simon Weonsang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6387126/ https://www.ncbi.nlm.nih.gov/pubmed/30700007 http://dx.doi.org/10.3390/ijms20030581 |
Ejemplares similares
-
Hippo-YAP/TAZ signaling in angiogenesis
por: Park, Jeong Ae, et al.
Publicado: (2018) -
Activated TAZ induces liver cancer in collaboration with EGFR/HER2 signaling pathways
por: Moon, Hyuk, et al.
Publicado: (2022) -
Hippo Pathway-independent Restriction of TAZ and YAP by Angiomotin
por: Chan, Siew Wee, et al.
Publicado: (2011) -
Role of Hippo Pathway-YAP/TAZ Signaling in Angiogenesis
por: Boopathy, Gandhi T. K., et al.
Publicado: (2019) -
Control of skeletal morphogenesis by the Hippo-YAP/TAZ pathway
por: Vanyai, Hannah K., et al.
Publicado: (2020)